Cisatracurium
Back to searchMolecule Structure
Scientific Name
Cisatracurium
Description of the Drug
Cisatracurium is a skeletal muscle relaxant used to facilitate tracheal intubation, muscle relaxation in surgery, or mechanical ventilation.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-02-07 from
http://www.drugbank.ca/drugs/DB00565
http://www.drugbank.ca/drugs/DB00565
Brand Name(s)
Nimbex
Company Owner(s)
Sagent Pharmaceuticals Inc, Abbvie Inc, Piramal Healthcare Uk Ltd, Meitheal Pharmaceuticals Inc, Sandoz Inc, Fresenius Kabi Usa Llc, Hospira Inc, Jiangsu Hengrui Medicine Co Ltd, Zydus Pharmaceuticals Usa Inc, Aurobindo Pharma Ltd
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Muscle-type nicotinic acetylcholine receptor | PROTEIN COMPLEX GROUP | ANTAGONIST | CHEMBL2362997 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL13057748 | ||
Human Metabolome Database | HMDB0240286 | ||
DrugBank | DB00565 | ||
PubChem | 62887 | ||
LINCS | LSM-45935 | ||
Nikkaji | J690.205G | ||
EPA CompTox Dashboard | DTXSID60873212 | ||
DrugCentral | 661 | ||
GSRS | 80d15c1f-ed29-4756-922d-382a34ba2344 | 34397aca-985c-471d-bd4b-0b92769edeb2 | |
rxnorm | NIMBEX | CISATRACURIUM | CISATRACURIUM BESYLATE |
ChEBI | 140621 | ||
ZINC | ZINC000238809664 |